AgeX Therapeutics Reports Second Quarter 2023 Financial Results

AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30,...
-Today at 04:06 pm- MarketScreener

Related Keywords

Alabama ,United States ,Paris ,France General ,France ,America ,American ,Jean Christophe Renondin ,Michaeld West ,Juvenescence Limited ,Serina Therapeutics Inc ,Linkedin ,Sovereign Fund Of Oman ,Exchange Commission ,Agex Therapeutics Inc ,Cognate Bioservices ,Hackett ,Youtube ,Transition Services ,Exchange Agreement ,Compensation Committee ,Tuck School Of Business At Dartmouth University ,Facebook ,Viscogliosi Brothers Acquisition Corp ,Twitter ,Audit Committee ,Charles River Laboratories International ,Bryan Garnier Co ,Agex Therapeutics ,Preferred Stock ,Seriesb Preferred Stock ,Accounting Standards Update ,Financial Statements Going Concern ,Quarterly Report ,Separation Agreement ,Chief Executive Officer ,Reverse Bioengineering ,Serina Therapeutics ,Employment Agreement ,Joanne Hackett ,Interim Chief Executive ,Interim Chief Executive Officer ,Corporate Governance Committee ,Consulting Agreement ,Managing Partner ,Vesalius Biocapital ,Senior Healthcare Manager ,Sovereign Fund ,North America ,Bryan Garnier ,Cognate Bioservices Limited ,Tuck School ,Dartmouth University ,Universite Paris ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,